| Financial Year |
March 31 2023 |
| Monetary Funds |
139,923,079.25 |
| Held-for-trading Financial Assets |
130,718,734.25 |
| Notes Receivable |
-- |
| Accounts Receivable |
90,850,140.48 |
| Advances to Suppliers |
9,986,854.32 |
| Other Receivables |
3,278,579.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
60,273,909.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,115,896.90 |
| Total Current Assets |
443,147,194.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,668,110.27 |
| Fixed Assetes |
212,143,584.18 |
| Under-construction Projects |
57,616,805.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,182,518.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,915,642.98 |
| Deferred Income Tax Assets |
8,840,827.21 |
| Other Non-Current Assets |
3,928,195.92 |
| Sub-Total of Non-Current Assets |
349,986,665.87 |
| Total Assets |
793,133,859.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,612,256.99 |
| Accounts Payable |
66,991,792.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,470,587.65 |
| Taxes Payable |
3,558,891.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,200,241.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,638,558.19 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
94,471,541.93 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
578,095.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
14,422,074.01 |
| Total Liabilities |
108,893,615.94 |
| Paid-In Capital(Or Share Stock) |
115,600,000.00 |
| Capital Surplus |
200,417,940.46 |
| Surplus Reserve |
24,231,258.98 |
| LESS:Treasury Stock |
5,054,504.00 |
| Undistributed Profits |
349,725,550.37 |
| Minority Stockholder's Interest |
4,243,437.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
679,996,806.90 |
| Owner's Equity（Stockholder's Equity） |
684,240,243.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
793,133,859.90 |
